Neuromodulation devices market will reach $8.1bn in 2018, predicts new study

LONDON - Nov. 11, 2014 - PRLog -- A new report by visiongain forecasts neuromodulation device revenues will reach $8.1bn worldwide in 2018. That medical device industry generated $4.9bn in 2013, according to Neuromodulation Devices: World Industry and Market 2015-2025, published in November 2014. Visiongain is a business information publisher and consultancy in London, UK.

That study predicts markets for neuromodulation (neurostimulation) therapies will show strong revenue growth from 2015 to 2025. An ageing world population and rising prosperity, with higher demands for healthcare, along with advances in medical technology, stimulate the neuromodulation market. Also its research and development (R&D) holds promise. Many technological and commercial opportunities for neurostimulation emerge from 2014, the study explains.

Neuromodulation technologies treat symptoms – such as chronic pain and tremor – associated with neurological disorders. Applications expand to include treating depression, epilepsy, incontinence, hearing disorders, heart conditions and neurodegenerative diseases.

Bochung Lam, a healthcare industry analyst in visiongain, said: “There remains a largely underserved market for neuromodulation devices that can not only treat the symptoms of pain and tremor, but significantly improve patients’ quality of life. Neuromodulation forms one of the most rapidly expanding sectors in medical treatment. And efforts from manufacturers will expand that large, lucrative market in the coming 10 years.

“Our study notes there is a greater demand for alternative forms of treatment when dealing with certain diseases associated with ageing, such as chronic pain and tremor. The number of patients suffering from those disorders will increase from 2015 to 2015, owing to ageing populations and changing lifestyles. Some patients cannot take pharmacological treatment because of allergies or side-effects. Neuromodulation offers a solution to that issue, and visiongain expects demand to increase rapidly from now to 2025.

“Our research shows regulations will form a challenge during the forecast period 2015 to 2025. However those difficulties will be overshadowed by the increased rate of adoption of these devices and their addressing a wider market. The future looks promising for neuromodulation.”

Visiongain’s new study predicts overall world revenue to 2025 for neuromodulating and neurostimulating technologies, also with predictions for five submarkets at world level:

Spinal cord stimulation (SCS)
Deep brain stimulation (DBS)
Vagal nerve stimulation (VNS)
Sacral nerve stimulation (SNS)
Other techniques for modifying CNS activity.

The research, data and analyses cover activities of Medtronic, Boston Scientific, St. Jude Medical and Cyberonics, among other companies, including rising and emerging firms.

That investigation discusses R&D, leading companies and commercial news. It also predicts individual revenues to 2025 in leading regional and national markets:

United States (US)
Japan
Germany, France, UK, Italy, Spain and Ireland, also with EU regional prediction
Brazil, Russia, India and China (BRIC nations).

The new investigation includes qualitative analyses – SWOT and STEP forces – and interviews with two companies.

Neuromodulation Devices: World Industry and Market 2015-2025 adds to visiongain’s range of reports on industries and markets in healthcare. Those studies cover pharmaceuticals, diagnostics and medicical devices.

For sample pages and further information concerning the visiongain Neuromodulation Devices World Industry and Market 2015-2025 report please visit: https://www.visiongain.com/Report/1348/Neuromodulation-Devices-World-Industry-and-Market-2015-2025

For an executive summary please contact:
Email: Sara Peerun on sara.peerun@visiongainglobal.com

Tel: +44 (0) 20 7336 6100

Notes for Editors
If you are interested in a more detailed overview of this report, please send an e-mail to sara.peerun@visiongainglobal.com or call her on +44 (0) 207 336 6100

About visiongain
Visiongain is one of the fastest growing and most innovative independent media companies in Europe. Based in London, UK, visiongain produces a host of business-2-business conferences, newsletters, management reports and e-zines focusing on the Energy, Telecoms, Pharmaceutical, Defence, Materials sectors.

Visiongain publishes reports produced by its in-house analysts, who are qualified experts in their field. Visiongain has firmly established itself as the first port-of-call for the business professional, who needs independent, high quality, original material to rely and depend on.